Inventor · disambiguated record
Kay Brickmann
Also filed as: BRICKMANN KAY
4 granted patents·14 pending applications·5 citations·filing 2003–2010
61Inventor score
Files withASTRAZENECA AB18
Top patents by PatentIndex Score
18 records- 0167US7582629B2Derivatives of isothiazol-3(2H)-one 1,1-dioxides as liver X receptor modulatorsASTRAZENECA AB·Filed 2006·Granted Sep 1, 2009·1 cites·26 claims
- 0264US7432288B2Pyrrole-2,5-dione derivatives as Liver X receptor modulatorsASTRAZENECA AB·Filed 2004·Granted Oct 7, 2008·4 cites·12 claims
- 0357US2011059981A9New Pyridine Analogues VASTRAZENECA AB·Filed 2007·Application pending·0 cites
- 0455US2010016321A1Derivatives of isothiazol-3(2h)-one 1,1-dioxides as liver x receptor modulatorASTRAZENECA AB·Filed 2009·Application pending·0 cites
- 0552US2008032992A1New Pyridine Analogues VASTRAZENECA AB·Filed 2007·Application pending·0 cites
- 0651US2009186876A1Pyridine Analogues IIASTRAZENECA AB·Filed 2007·Application pending·0 cites
- 0751US2007244088A1New Pyridine Analogues IIASTRAZENECA AB·Filed 2007·Application pending·0 cites
- 0849US2008200448A1New Pyridine Analogues VIII 518ASTRAZENECA AB·Filed 2008·Application pending·0 cites
- 0949US2008176827A1New Pyridine Analogues VII 543ASTRAZENECA AB·Filed 2008·Application pending·0 cites
- 1047US7723333B2Non-anilinic derivatives of isothiazol-3(2H)-one 1,1-dioxides as liver X receptor modulatorsASTRAZENECA AB·Filed 2006·Granted May 25, 2010·0 cites·26 claims
- 1143US2009306133A1New Acetyl Coenzyme A Carboxylase (ACC) Inhibitors And Uses In Treatments Of Obesity And Diabetes Mellitus - 087ASTRAZENECA AB·Filed 2008·Application pending·0 cites
- 1241US2008312208A1Pyridine AnaloguesASTRAZENECA AB·Filed 2006·Application pending·0 cites
- 1340US2009227555A2Novel Pyridine CompoundsASTRAZENECA AB·Filed 2006·Application pending·0 cites
- 1439US7960380B2Non-anilinic derivatives of isothiazol-3(2H)-one 1,1-dioxides as liver X receptor modulatorsASTRAZENECA AB·Filed 2010·Granted Jun 14, 2011·0 cites·17 claims
- 1539US2009029945A2Non-Anilinic Derivatives of Isothiazol-3(2H)-Thione 1,1-Dioxides As Liver X Receptor ModulatorsASTRAZENECA AB·Filed 2006·Application pending·0 cites
- 1639US2008319017A2Non-Anilinic Derivatives of Isothiazol-3(2H)-Thione 1,1-Dioxides As Liver X Receptor ModulatorsASTRAZENECA AB·Filed 2006·Application pending·0 cites
- 1737US2006247439A1Mchir antagonistsASTRAZENECA AB·Filed 2003·Application pending·0 cites
- 1835US2008300232A1N-Piperidine Derivatives as Ccr3 ModulatorsASTRAZENECA AB·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Kay Brickmann files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →